Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Tanna, P; Strauss, RW; Fujinami, K; Michaelides, M.
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options.
Br J Ophthalmol. 2017; 101(1): 25-30.
Doi: 10.1136/bjophthalmol-2016-308823
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Strauß Rupert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Stargardt disease (STGD1; MIM 248200) is the most prevalent inherited macular dystrophy and is associated with disease-causing sequence variants in the gene ABCA4 Significant advances have been made over the last 10 years in our understanding of both the clinical and molecular features of STGD1, and also the underlying pathophysiology, which has culminated in ongoing and planned human clinical trials of novel therapies. The aims of this review are to describe the detailed phenotypic and genotypic characteristics of the disease, conventional and novel imaging findings, current knowledge of animal models and pathogenesis, and the multiple avenues of intervention being explored.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
- Find related publications in this database (using NLM MeSH Indexing)
-
ATP-Binding Cassette Transporters - genetics
-
Animals -
-
Disease Models, Animal -
-
Electroretinography -
-
Female -
-
Genetic Therapy - methods
-
Genotype -
-
Humans -
-
Macular Degeneration - congenital
-
Macular Degeneration - genetics
-
Macular Degeneration - pathology
-
Macular Degeneration - physiopathology
-
Macular Degeneration - therapy
-
Molecular Biology -
-
Mutation -
-
Phenotype -